Vir Biotechnology Statistics
NASDAQ: VIRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
11.52-0.08 (-0.69%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Vir Biotechnology by the numbers
Vir Biotechnology has a market capitalization of $1.95 billion based on 169.22M shares outstanding. With trailing EPS of $-1.76, Vir Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.3% above its 50-day average and 26.9% above its 200-day average.
Average daily trading volume is 1.87M shares, or about $21.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VIR valuation vs. peer median
| Metric | VIR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.95B | $2.09B | -7% |
| Avg. volume | 1.87M | 1.83M | +2% |
Peer median across 8 companies: NVAX, VCEL, ALVO, MESO, BCRX, ADMA, RXRX, IMCR.
Valuation
- Market cap
- $1.95B
- EPS (TTM)
- $-1.76
- Shares outstanding
- 169.22M
Price and trading
- Previous close
- 11.60
- Open
- 11.32
- Day range
- 11.32 – 11.77
- 52-week range
- 4.82 – 11.94
- 52-week change
- +103.53%
- Beta
- —
- Volume
- 3.56M
- Average volume
- 1.87M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.95B
- Forward Pe
- -4.63
- Eps
- -1.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.94
- Week52 Low
- 4.82
- Avg Volume
- 1.87M
- Shares Outstanding
- 169.22M
- Ma50
- 10.25
- Ma200
- 9.08
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -3.52%
- Pct From52w Low
- 139.25%